Lv4
464 积分 2024-09-12 加入
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
3天前
已完结
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
12天前
已完结
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
12天前
已完结
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
23天前
已完结
Abstract 7525: Investigating B7-H3 as a checkpoint and antibody drug conjugate target across prostate cancer variants- both androgen receptor dependent and independent
25天前
已关闭
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
25天前
已完结
The landscape of cancer research and cancer care in China
28天前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
1个月前
已完结
Towards in vitro models for reducing or replacing the use of animals in drug testing
1个月前
已完结
Preclinical evaluation of a dual-receptor targeted tracer [68Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models
1个月前
已完结
皖公网安备34019202002308
